Sanofi, Glaxo advance talks to supply up to 300 million COVID-19 vaccine doses to Europe – companies

The doses would be manufactured in European countries including France, Belgium, Germany and Italy.
Sanofi is leading the clinical development of the vaccine and expects to launch a pivotal trial by the end of this year.

(Refiles to correct typographical error in headline to “doses” instead of “does”)
(Reporting By Deena Beasley; editing by Grant McCool)
Autel Diagnostic Tool